<< Read Full Article
<< Read Full Article
Abiomed(ABMD Quote) late Thursday issued downside revenue guidance for its second quarter ended Sept. 30.
The maker of heart-pumping devices forecast sales of $11 million, below Street consensus of $13.3 million in revenue, but a tad higher than reported revenue in the same period last year of $10.9 million.
"Our strategic platforms of Impella and AB5000 (consoles and disposables) performed well during the quarter," said CEO Michael Minogue, who added that revenue for BVS (blood pumps) declined. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet